- Home
- MRNA vs EPAM Comparison
MRNA vs EPAM Comparison
Compare MRNA & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- EPAM
- Stock Information
- Founded
- MRNA 2010
- EPAM 1993
- Country
- MRNA United States
- EPAM United States
- Employees
- MRNA N/A
- EPAM N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- EPAM EDP Services
- Sector
- MRNA Health Care
- EPAM Technology
- Exchange
- MRNA Nasdaq
- EPAM Nasdaq
- Market Cap
- MRNA 10.9B
- EPAM 9.8B
- IPO Year
- MRNA 2018
- EPAM 2012
- Fundamental
- Price
- MRNA $25.87
- EPAM $154.67
- Analyst Decision
- MRNA Hold
- EPAM Buy
- Analyst Count
- MRNA 19
- EPAM 14
- Target Price
- MRNA $43.50
- EPAM $222.21
- AVG Volume (30 Days)
- MRNA 12.2M
- EPAM 802.9K
- Earning Date
- MRNA 11-06-2025
- EPAM 11-06-2025
- Dividend Yield
- MRNA N/A
- EPAM N/A
- EPS Growth
- MRNA N/A
- EPAM 0.62
- EPS
- MRNA N/A
- EPAM 7.02
- Revenue
- MRNA $3,078,000,000.00
- EPAM $5,071,013,000.00
- Revenue This Year
- MRNA N/A
- EPAM $16.65
- Revenue Next Year
- MRNA $10.17
- EPAM $7.20
- P/E Ratio
- MRNA N/A
- EPAM $21.88
- Revenue Growth
- MRNA N/A
- EPAM 9.73
- 52 Week Low
- MRNA $23.15
- EPAM $138.15
- 52 Week High
- MRNA $75.37
- EPAM $269.00
- Technical
- Relative Strength Index (RSI)
- MRNA 51.44
- EPAM 38.76
- Support Level
- MRNA $23.18
- EPAM $152.10
- Resistance Level
- MRNA $25.90
- EPAM $158.65
- Average True Range (ATR)
- MRNA 1.16
- EPAM 5.37
- MACD
- MRNA 0.27
- EPAM -1.71
- Stochastic Oscillator
- MRNA 95.05
- EPAM 12.86
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.